Join
Live feed
·
INSIDERFilingvia Quantisnow
Athira Pharma Inc. logo

CHIEF SCIENTIFIC OFFICER Church Kevin was granted 9,920 shares, converted options into 36,667 shares and sold $4,782 worth of shares (8,510 units at $0.56), increasing direct ownership by 41% to 130,761 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATHA (Athira Pharma Inc.) and more on Quantisnow.